Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Postmenopausal women, more than 5 years post menopause~* Osteopenia (T-score \< -1 and \> -2.5)~* Low risk of fracture (FRAX: \< 20 major osteoporotic; \< 3 hip fracture)~Exclusion Criteria:~* Hyperkalemia~* Renal insufficiency~* Nephrolithiasis~* Use of potassium sparing diuretics~* Use of potassium supplements~* Use of therapies influencing bone metabolism (e.g. corticosteroids, thiazide diuretics, aromatase inhibitors, estrogens)~* Use of protonic pump inhibitors~* Current or recent use of bisphosphonates (stopped less than three years prior to the start of the study)~* Gastrointestinal disorders that hamper nutrient absorption;~* Mental or psychiatric disorders that preclude the possibility of correctly adhering to the protocol

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment group (Type: EXPERIMENTAL): Potassium citrate Calcium carbonate Vitamin D3
- Control group, Placebo (Type: PLACEBO_COMPARATOR): Placebo (Excipients) Calcium carbonate Vitamin D3

Based on this trial design, predict the completion outcome and termination type (if applicable).